Sophia Genetics

Sophia Genetics

Quarterly Financials

Values in thousands2026-06-302026-03-312025-12-312025-09-30
Revenue
$23,310
$21,688
$21,707
$19,462
Gross Profit
15,061
14,749
14,692
12,907
EBITDA
-17,751
-14,651
-15,463
-17,243
EBIT
-20,658
-17,402
-17,901
-18,338
Net Income
-22,356
-19,322
-19,179
-20,021
Net Change In Cash
23,310
21,688
21,707
19,462
Free Cash Flow
-10,389
-17,057
-9,283
-8,899
Cash
107,665
65,391
70,289
81,610
Basic Shares
73,838
71,137
68,241
67,787

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$77,271
$65,173
$62,371
$47,560
Gross Profit
47,814
43,937
42,913
31,254
EBITDA
-64,404
-50,761
-69,571
-81,375
EBIT
-73,933
-59,357
-77,907
-86,946
Net Income
-78,999
-62,493
-78,981
-87,449
Net Change In Cash
77,271
65,173
62,371
47,560
Free Cash Flow
-38,585
-50,998
-57,801
-80,474
Cash
70,289
80,226
123,251
161,305
Basic Shares
67,539
65,782
64,750
64,099

Earnings Calls

QuarterEPS
2026-06-30
-$0.26
2026-03-31
-$0.19
2025-12-31
-$0.17
2025-09-30
-$0.20